Pharmaceutical Products Companies By Roe

Return On Equity
ROEEfficiencyMarket RiskExp Return
1DTIL Precision BioSciences
0.24
 0.08 
 6.29 
 0.48 
2TLX Telix Pharmaceuticals Limited
0.2
 0.07 
 3.32 
 0.23 
3XOMAP XOMA Corp
0.15
 0.04 
 0.54 
 0.02 
4XOMAO XOMA Corporation
0.15
 0.07 
 0.28 
 0.02 
5ZYBT Zhengye Biotechnology Holding
0.0715
 0.13 
 6.48 
 0.85 
6DVAX Dynavax Technologies
0.0448
 0.08 
 1.48 
 0.11 
7VCEL Vericel Corp Ord
0.04
(0.11)
 2.57 
(0.28)
8037411AR6 APACHE P 6
0.0
(0.04)
 1.95 
(0.07)
9MDCX Medicus Pharma Ltd
0.0
 0.07 
 8.70 
 0.61 
10037411AY1 APACHE P 525
0.0
 0.01 
 2.16 
 0.01 
1163938CAJ7 Navient 675 percent
0.0
(0.04)
 0.48 
(0.02)
1263938CAL2 US63938CAL28
0.0
(0.04)
 1.83 
(0.08)
1363938CAK4 Navient 5 percent
0.0
 0.02 
 0.80 
 0.01 
1463938CAM0 US63938CAM01
0.0
(0.10)
 1.60 
(0.17)
15MNKD MannKind Corp
0.0
(0.23)
 1.93 
(0.45)
16037411AW5 APACHE P 51
0.0
(0.04)
 2.31 
(0.10)
1763938CAH1 Navient 675 percent
0.0
(0.09)
 0.32 
(0.03)
18037411BC8 APACHE P 425
0.0
 0.01 
 2.65 
 0.03 
19MTSR Metsera, Common Stock
0.0
 0.19 
 9.22 
 1.74 
20037411BE4 APACHE P 4375
0.0
(0.04)
 0.78 
(0.03)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income. For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.